Squalene and cholesterol

What 3 graded rows on squalene agree on for cholesterol, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Squalene page, with its PubMed record.

Your question

Supplement

Squalene and cholesterol

3 rows · 135 people

Split. 1 row found an improvement, 1 found no difference and 1 found a worse outcome.

No difference or worse
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside. Red: a worse outcome.
  • Grade D× 3
Rows
3
Trials
3
People
135

Where they differ

From the rows
Trial sizeHow longWhen published

The best-graded row, grade D, is a randomized trial of 102 people (1996) and found an improvement.

The row that found an improvement was larger: 102 people, against 15 people for the row that found no difference.

The row that found an improvement ran longer (5 months) than the row that found no difference (7 days).

The row that found an improvement is newer (1996) than the row that found no difference (1990).

The rows

1 improved · 1 no difference · 1 worse
  1. Grade DTotal and LDL cholesterol in older adults with high cholesterol · Improved

    RCT · n 102 · 1996 · Adults over 65 with primary hypercholesterolaemia after diet run-in

    860 mg/day with the evening meal · 20 weeks

    Squalene alone lowered total and LDL cholesterol versus placebo (per the 2020 systematic review of the full text), but less than 10 mg pravastatin; the combination lowered LDL most. Adverse events were mild and transient.

    Row on the Squalene page · PubMed 8739021 (opens PubMed)

  2. Grade DSerum cholesterol and cholesterol synthesis during squalene feeding · No difference

    Open-label trial · n 15 · 1990 · Patients with cerebrovascular or cardiovascular disease and varying cholesterol levels

    900 mg/day (300 mg three times daily) · 7–30 days

    About 60% of the squalene was absorbed and blood squalene rose 17-fold, but serum cholesterol and triglycerides did not change; fecal sterol output showed cholesterol synthesis rose by about 50%.

    Row on the Squalene page · PubMed 2246614 (opens PubMed)

  3. Grade DSerum cholesterol when squalene was added to rapeseed oil · Worse

    Open-label trial · n 18 · 1994 · Men with high cholesterol (mean age 50)

    1 g/day, then 0.5 g/day · 9 weeks at 1 g/day, then 6 weeks at 0.5 g/day

    At 1 g/day, serum total, VLDL, IDL and LDL cholesterol rose by 12%, 34%, 28% and 12% and LDL apolipoprotein B by 14%; lowering the dose to 0.5 g/day returned serum sterols to normal.

    Row on the Squalene page · PubMed 8310985 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.